reports
- GlobalData Healthcare Department
LegoChem Biosciences Inc (141080) - Financial Analysis Review
LegoChem Biosciences Inc (141080) - Financial Analysis Review Summary LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. GlobalData's...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.